Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease.
Saved in:
| Title: | Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease. |
|---|---|
| Authors: | Powell NR; Indiana University School of Medicine, Department of Medicine, Division of Clinical Pharmacology, Indianapolis, IN, USA., Liang T; Indiana University School of Medicine, Department of Medicine, Division of Gastroenterology Hepatology, Indianapolis, IN, USA., Ipe J; Indiana University School of Medicine, Department of Medicine, Division of Clinical Pharmacology, Indianapolis, IN, USA., Cao S; Indiana University School of Medicine, Department of Medicine, Division of Gastroenterology Hepatology, Indianapolis, IN, USA., Skaar TC; Indiana University School of Medicine, Department of Medicine, Division of Clinical Pharmacology, Indianapolis, IN, USA., Desta Z; Indiana University School of Medicine, Department of Medicine, Division of Clinical Pharmacology, Indianapolis, IN, USA., Qian HR; Eli Lilly and Company, Indianapolis, IN, USA., Ebert PJ; Eli Lilly and Company, Indianapolis, IN, USA., Chen Y; Eli Lilly and Company, Indianapolis, IN, USA., Thomas MK; Eli Lilly and Company, Indianapolis, IN, USA., Chalasani N; Indiana University School of Medicine, Department of Medicine, Division of Gastroenterology Hepatology, Indianapolis, IN, USA. nchalasa@iu.edu. |
| Source: | Nature communications [Nat Commun] 2023 Mar 17; Vol. 14 (1), pp. 1474. Date of Electronic Publication: 2023 Mar 17. |
| Publication Type: | Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
